RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma.
Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
这些发现表明 INTS 家族基因有潜力作为 HCC 的诊断生物标志物和治疗靶点。需要进一步研究以了解其潜在机制并探索临床应用。
肝细胞癌(HCC)是一种常见的消化道恶性肿瘤,发病率高且预后差。整合体复合物亚基(INTS1-14)在调控依赖 RNA 聚合酶 II 的基因中发挥关键作用,这可能与癌症相关。然而,INTSs 在 HCC 中的作用仍不清楚。本研究旨在通过系统的生物信息学分析,全面分析 INTS 家族基因在 HCC 中的临床价值和潜在作用。
我们利用多种公共数据库,包括UALCAN、HPA、Kaplan-Meier Plotter、GEPIA2、TNMplot、STRING、TIMER和TISIDB,研究INTSs在HCC中的表达水平、临床病理相关性、诊断和预后价值、基因改变、共表达网络、分子靶点和免疫浸润。此外,利用基因本体论(GO)和京都基因与基因组百科全书(KEGG)研究INTSs相关基因的生物学功能。此外,采用Western blot、实时荧光定量逆转录聚合酶链反应(RT-qPCR)和免疫组织化学技术评估相关蛋白和基因的表达。使用CCK8 assay评估HCC细胞的增殖。
我们发现,在HCC中,INTSs在转录水平上显著上调,尤其是INTS1、INTS4、INTS7和INTS8。此外,INTS1和INTS8的蛋白水平也显著升高。这些INTSs的过表达与HCC患者的肿瘤分期密切相关。INTS1、INTS4、INTS7和INTS8在HCC中表现出显著的诊断和预后价值。此外,它们的表达与免疫浸润和激活状态相关,包括B细胞、CD8 + T细胞、CD4 + T细胞、NK细胞、巨噬细胞和树突状细胞。功能预测表明,INTS1、INTS4、INTS7和INTS8参与多种癌症相关信号通路,如TRAIL、IFN-gamma、mTOR、CDC42、Apoptosis和p53通路。此外,我们观察到与正常肝细胞系相比,HCC细胞系中INTS1、INTS4、INTS7和INTS8的表达显著上调。与癌旁非癌组织相比,癌组织中INTS1蛋白水平更高(n = 16),并且抑制INTS1导致Huh7细胞增殖显著减少。
Hepatocellular carcinoma (HCC) is a common gastrointestinal malignancy with a high incidence and poor prognosis. The subunits of the integrator complex (INTS1-14) play a crucial role in regulating genes dependent on RNA Polymerase II, which may be associated with cancer. However, the role of INTSs in HCC remains unclear. This study aims to comprehensively analyze the clinical value and potential role of INTS family genes in HCC through systematic bioinformatics analysis.
We employed various public databases, including UALCAN, HPA, Kaplan-Meier Plotter, GEPIA2, TNMplot, STRING, TIMER, and TISIDB, to investigate the expression levels, clinicopathological correlations, diagnostic and prognostic value, genetic alterations, co-expression network, molecular targets, and immune infiltration of INTSs in HCC. Additionally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to investigate the biological functions of genes associated with INTSs. Furthermore, Western blot, real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-qPCR), and immunohistochemistry techniques were employed to assess the expression of relevant proteins and genes. The proliferation of HCC cells was evaluated using the CCK8 assay.
We found that in HCC, there was a significant upregulation of INTSs at the transcriptional level, particularly INTS1, INTS4, INTS7, and INTS8. Additionally, the protein levels of INTS1 and INTS8 were notably elevated. The overexpression of these INTSs was strongly correlated with tumor stages in HCC patients. INTS1, INTS4, INTS7, and INTS8 exhibited significant diagnostic and prognostic value in HCC. Moreover, their expression was associated with immune infiltrations and activated status, including B cells, CD8 + T cells, CD4 + T cells, NK cells, macrophages, and dendritic cells. Functional predictions indicated that INTS1, INTS4, INTS7, and INTS8 were involved in various cancer-related signaling pathways, such as TRAIL, IFN-gamma, mTOR, CDC42, Apoptosis, and the p53 pathway. Furthermore, we observed a significant upregulation of INTS1, INTS4, INTS7, and INTS8 expression in HCC cell lines compared to normal liver cell lines. The level of INTS1 protein was higher in cancerous tissues compared to adjacent non-cancerous tissues (n = 16), and the suppression of INTS1 resulted in a significant decrease in the proliferation of Huh7 cells.
These findings indicate the potential of INTS family genes as diagnostic biomarkers and therapeutic targets in HCC. Further research is needed to understand the underlying mechanisms and explore clinical applications.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。